Brazil exceeds 100 million distributed doses of coronavirus vaccine

Brazil exceeded 100 million doses of vaccine against Covid-19 distributed throughout the country since the launch of its national vaccination plan on January 18

Sputnik V, Dr Reddy's Laboratories, DRL, coronavirus, vaccine, covid-19
IANS Brasilia
2 min read Last Updated : Jun 03 2021 | 6:52 AM IST

Brazil exceeded 100 million doses of vaccine against Covid-19 distributed throughout the country since the launch of its national vaccination plan on January 18, the Ministry of Health said on Wednesday.

"This is an important mark because it represents the realization of our effort to ensure vaccination to the Brazilian population. We are taking care of lives with a dose of hope," said Health Minister Marcelo Queiroga, Xinhua reported.

To date, the South American country has immunized 54 million people, or a third of the target population, according to the ministry, with the goal of inoculating the entire population by the end of 2021.

Brazil's vaccination campaign began with the use of the CoronaVac vaccine developed by Chinese pharmaceutical company Sinovac, which was later joined by the AstraZeneca-Oxford vaccine and recently by the vaccine from US laboratory Pfizer.

The government has contracted more than 600 million doses to be delivered through the end of the year, according to ministry data.

This week, the Brazilian government will ship doses of the vaccines to begin the immunization of education workers.

Meanwhile, the inoculation of people with comorbidities and permanent disabilities, pregnant and postpartum women, Afro-descendant and coastal communities, and air transport workers continues.

The vaccination of the general population has been authorized in descending order of age for people under 60 years old, once the immunization of the most vulnerable priority groups and education workers has been completed.

As of Tuesday, Brazil had over 16.62 million COVID-19 cases and 465,199 deaths, according to the latest Health Ministry report. ¦

--IANS

int/pgh

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusBrazilCoronavirus VaccineCoronavirus Tests

First Published: Jun 03 2021 | 6:50 AM IST

Next Story